INTERNATIONAL PATENT: SHENZHEN TARGETRX CO., LTD., 深圳市塔吉瑞生物医药股份有限公司 FILES APPLICATION FOR "C-KIT OR PDGFRΑ-TARGETED PROTEOLYSIS TARGETING CHIMERA COMPOUND AND COMPOSITION AND USE THEREOF"

Posted On: 2026-04-05

GENEVA, April 5 -- SHENZHEN TARGETRX CO., LTD. (Third Floor, Building A1 Kexing Science Park, No.15 Of Keyuan Road, Yuehai Subdistrict, Nanshan DistrictShenzhen, Guangdong 518057), 深圳市塔吉瑞生物医药股份有限公司 (中国广东省深圳市南山区粤海街道科苑路15号科兴科学园A1栋3层) filed a patent application (PCT/CN2025/125087) for "C-KIT OR PDGFRAlpha-TARGETED PROTEOLYSIS TARGETING CHIMERA COMPOUND, AND COMPOSITION AND USE THEREOF" on Sep 29, 2025. With publication no. WO/2026/067739, the details rela...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHENZHEN TARGETRX CO., LTD., 深圳市塔吉瑞生物医药股份有限公司 FILES APPLICATION FOR "C-KIT OR PDGFRΑ-TARGETED PROTEOLYSIS TARGETING CHIMERA COMPOUND AND COMPOSITION AND USE THEREOF"